SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-06-005664
Filing Date
2006-04-10
Accepted
2006-04-10 16:40:49
Documents
1
Period of Report
2006-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7850
  Complete submission text file 0001140361-06-005664.txt   9830
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3385 WEST 1820 SOUTH SALT LAKE CITY UT 84104
Business Address 8019751191
SEMBER MICHAEL T (Reporting) CIK: 0001107486 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 06751254